BTN2A1

BTN2A1 is a transmembrane butyrophilin family member that functions as a germline ligand for the Vγ9Vδ2 T cell receptor and a key mediator of phosphoantigen-dependent γδ T cell activation. BTN2A1 forms a heteromeric complex with BTN3A isoforms at the cell surface; intracellularly, the microbial phosphoantigen HMBPP bridges the B30.2 domains of BTN3A1 and BTN2A1, inducing conformational changes that prime the BTN2A1 IgV ectodomain to directly engage the Vγ9 chain of the TCR, while BTN3A2 contacts the Vδ2 chain, together triggering cytotoxicity (PMID:34260935, PMID:36995939, PMID:37171180). BTN2A1 homodimerization via its B30.2 domain is required for phosphoantigen responsiveness, and TCR and BTN3A1-IgV binding sites on BTN2A1-IgV are mutually exclusive, supporting a composite-ligand model of activation (PMID:37171180, PMID:36995939). Beyond γδ T cell biology, BTN2A1 serves as a ligand for DC-SIGN on dendritic cells through high-mannose glycosylation (PMID:17785817), and antibody-mediated BTN2A1 engagement on macrophages activates SYK–ERK signaling to reprogram M2-like macrophages toward an M1-like phenotype that enhances T cell responses (PMID:39325623).

1. 2007 High

   Establishing that BTN2A1 is a cell-surface glycoprotein recognized by the innate immune receptor DC-SIGN on dendritic cells, dependent on high-mannose glycosylation, provided the first evidence that BTN2A1 participates in immune cell communication.

   Evidence Ig-fusion binding assays, DC-SIGN transfectant binding, antibody blocking, and glycosylation analysis

   PMID:17785817

   Open questions at the time

   • Functional consequence of BTN2A1–DC-SIGN interaction on dendritic cell maturation or antigen presentation not determined
   • Whether DC-SIGN engagement modulates BTN2A1 signaling in the BTN2A1-expressing cell unknown
2. 2021 High

   Identification of BTN2A1 as an obligate co-receptor with BTN3A1 for Vγ9Vδ2 TCR activation resolved the long-standing question of how phosphoantigen sensing is translated into γδ T cell recognition, showing that BTN2A1 directly contacts the TCR and that its B30.2 domain is required for phosphoantigen responsiveness.

   Evidence Co-immunoprecipitation, BTN2A1/BTN3A1 reconstitution in cancer cells, anti-BTN2A1 mAb blocking, and cytotoxicity assays

   PMID:34260935

   Open questions at the time

   • Structural basis of the BTN2A1–TCR interaction not resolved at this point
   • Relative contributions of BTN3A isoforms (BTN3A1 vs BTN3A2 vs BTN3A3) to the complex not delineated
3. 2022 Medium

   Demonstrating that a heterodimeric BTN2A1/BTN3A1 fusion protein delivers 'signal 1' to the Vγ9Vδ2 TCR but requires costimulation for full T cell activation clarified that BTN2A1/BTN3A1 functions analogously to peptide–MHC for γδ T cells.

   Evidence Tumor cell-free reconstitution with heterodimeric fusion protein, CD28/NKG2D costimulation, granzyme B cytotoxicity assay

   PMID:36096643

   Open questions at the time

   • Costimulatory requirements not validated in vivo
   • Whether the fusion protein fully recapitulates native complex geometry remains uncertain
4. 2023 High

   NMR-based structural mapping revealed that TCR and BTN3A1-IgV bind overlapping sites on BTN2A1-IgV, establishing mutual exclusivity and supporting a composite-ligand model where intracellular phosphoantigen sensing coordinates distinct extracellular TCR contacts.

   Evidence NMR, molecular modeling, mutagenesis, TCR binding assays

   PMID:36995939

   Open questions at the time

   • Full atomic-resolution structure of the ternary TCR–BTN2A1–BTN3A1 extracellular complex not available from this study
   • Dynamics of the switch between BTN3A1-bound and TCR-bound states of BTN2A1 not resolved
5. 2023 High

   Discovering that BTN2A1 forms a disulfide-linked homodimer via its B30.2 domain, and that homodimerization is required for HMBPP-bound BTN3A1 recognition, established a critical intracellular gating mechanism for phosphoantigen sensing.

   Evidence NMR, size exclusion chromatography, site-directed mutagenesis (L325G), isothermal titration calorimetry, 31P-NMR

   PMID:37171180

   Open questions at the time

   • Whether BTN2A1 homodimerization is regulated by post-translational modifications in vivo not addressed
   • Stoichiometry of the full signaling complex at the membrane not determined
6. 2024 High

   Anti-BTN2A1 antibody engagement on M2-like macrophages was shown to recruit SYK and activate SYK–ERK signaling, reprogramming macrophages toward an M1-like state, revealing a previously unrecognized signaling function for BTN2A1 beyond TCR ligand activity.

   Evidence Anti-BTN2A1 mAb treatment, SYK/ERK phosphoprotein analysis, kinase inhibitor experiments, in vitro and ex vivo macrophage assays

   PMID:39325623

   Open questions at the time

   • Endogenous ligand or physiological trigger for BTN2A1-mediated macrophage signaling not identified
   • Whether SYK directly binds the BTN2A1 cytoplasmic domain or requires an adaptor unknown
7. 2024 High

   Cryo-EM structures of the full-length BTN3A1–BTN3A2–BTN2A1 complex revealed that HMBPP bridges BTN3A1 and BTN2A1 B30.2 domains intracellularly, and upon TCR engagement the BTN3A2–BTN2A1 ectodomain interaction dissociates so that BTN2A1 grips the Vγ9 chain laterally while BTN3A2 contacts the Vδ2 chain apically, establishing a 'pliers-like' activation mechanism.

   Evidence Cryo-EM structural determination of full-length complex and BTN multimer–TCR complex (preprint)

   Open questions at the time

   • Preprint not yet peer-reviewed
   • How membrane lipid environment influences the conformational switch remains unknown
   • Kinetics of ectodomain dissociation upon phosphoantigen loading not measured
8. 2025 High

   19F NMR of BTN3A1 point mutants showed that HMBPP and BTN2A1 association induce conformational changes at residues distant from the phosphoantigen-binding pocket (notably T506), demonstrating allosteric signal propagation through the BTN3A1 B30.2 domain.

   Evidence 19F solution NMR with BTN3A1 point mutants and binding affinity measurements

   PMID:40079188

   Open questions at the time

   • How allosteric changes in B30.2 are transmitted across the membrane to the ectodomain not structurally resolved at atomic level
   • Whether similar allostery occurs in BTN3A2 or BTN3A3 B30.2 domains not tested
9. 2025 Medium

   BTN2A1 can be transferred to lymphocytes via trogocytosis from activated monocytes, and trogocytosis-acquired BTN2A1 is functionally competent to sensitize cells to Vγ9Vδ2 T cell killing, revealing a non-transcriptional mechanism for regulating BTN2A1-dependent γδ T cell surveillance.

   Evidence BTN2A1-knockout B cell line, trogocytosis assay, flow cytometry, cytotoxicity assays

   PMID:41066236

   Open questions at the time

   • In vivo relevance of trogocytic BTN2A1 acquisition not demonstrated
   • Whether trogocytosis transfers the full BTN2A1/BTN3A complex or only BTN2A1 not resolved

• The mechanism by which intracellular phosphoantigen-induced conformational changes in the B30.2 domains are propagated across the membrane to remodel ectodomain architecture, and how BTN2A1's SYK-dependent signaling in macrophages is initiated at the molecular level, remain unresolved.
• No full transmembrane signaling mechanism linking B30.2 allostery to ectodomain rearrangement
• Endogenous trigger for BTN2A1-mediated macrophage SYK signaling unknown
• Whether BTN2A1 has a direct cytoplasmic signaling motif or requires adaptor proteins not established